Chimeric antigen receptor (CAR) T cell therapies have transformed treatment of B cell malignancies. However, their broader application is limited by complex manufacturing processes and the necessity for lymphodepleting chemotherapy, restricting patient …
In this GEN webinar, Veerendra Kumar Reddy, PhD, will introduce Enzene’s FCCM technology and discuss how it enables affordable and accessible protein therapeutics manufacturing.
Nabla, an AI assistant company, has raised $70 million in its series C funding round, led by HV Capital. | With the infusion of capital,…
A study by the Max Planck Institute found that combining rapamycin and trametinib extended mice lifespans by up to 30%, offering promising insights into potential…
Injections of mRNA may offer a simpler, cheaper way to build powerful CAR-T cells
On this week’s show: Visiting the Vera C. Rubin Observatory, and the impact of plastic bag regulations on reductions in marine litter
Developing lenacapavir, the drug newly approved to protect against HIV for six months in one shot, took basic science, sophisticated chemistry, and perseverance
The brain’s response to injury includes the activation of intrinsic microglia and the influx of leukocytes, collectively constituting neuroinflammation, the “flame” of the brain. Although…
Chimeric antigen receptor (CAR) T cell therapies have transformed treatment of B cell malignancies. However, their broader application is limited by complex manufacturing processes and…
Bridging knowledge gaps could enable regenerative therapy
Unique ability allows the animals to protect themselves and their offspring from decaying food and other material
